ArticleBMC cancer2025

Targeting the HIF1A-UCA1-PTBP3 axis: a potential therapeutic strategy for head and neck cancer.

Lydia Chin-Ling Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.